Glyburide, Micronized: Oral tablet (1.5mg)

Detailed Information

ON THIS PAGE:
What is this Medicine?
CVS Patient Statistics
In-Depth Information
Learn More
Patient Experiences

Also see:

Get answers to Frequently Asked Questions (FAQs)
Find other class related drugs
Find additional patient usage statistics

Visit Drug Summary Page

Check Drug Interactions

Refill Prescription Transfer Prescription

Glyburide (Micro) 1.5mg Tab
Mylan Pharmaceuticals Inc.

Pill Identification: M 113

Glyburide (Micro) 1.5mg Tab
Teva Pharmaceuticals USA

Pill Identification: N | 1.5 034

Glyburide (Micro) 1.5mg Tab

What is this Medicine?

GLYBURIDE (GLYE byoor ide) helps to treat type 2 diabetes. Treatment is combined with diet and exercise. The medicine helps your body to use insulin better.

Similar Brand Name Drugs : Glynase PresTab: Oral tablet (3mg) | Glynase PresTab: Oral tablet (6mg) | Glynase PresTab: Oral tablet (1.5mg)

CVS Pharmacy Patient Statistics for Glyburide, Micronized: Oral tablet(1.5mg)

Generic vs. Brand Name Usage*

*Brand contains same active ingredient but may not represent FDA-approved generic equivalent

Usage By Strength

In-Depth Information

Select a Medication

Glyburide (Micronized) 1.5mg Tablet

NDC: 003781113

Prescription Required
Not a Controlled Drug
(CSA Schedule)
FDA Approved

FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)

Glyburide (Micronized) 1.5mg Tablet

Mylan Pharmaceuticals Inc.

Pill Identification: M 113

Shape: oval

Color: white

Ingredients

Close All Sections

Reported Side Effects for Glyburide (Micronized) 1.5mg Tablet

Liver Infection Incidence: <1.0%* Severity: MODERATE
Onset: DELAYED

Pancytopenia Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Liver Failure Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Hemolysis Incidence: <0.1%* Severity: MODERATE
Onset: EARLY

Flushing Incidence: <0.1%* Severity: MILD
Onset: RAPID

Elevated Hepatic Enzymes Incidence: <1.0%* Severity: MODERATE
Onset: DELAYED

Inflamed Blood Vessels Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Low White Blood Cell Counts Incidence: <0.1%* Severity: MODERATE
Onset: DELAYED

Yellow Skin Incidence: <1.0%* Severity: MODERATE
Onset: DELAYED

Angioedema Incidence: <0.1%* Severity: SEVERE
Onset: RAPID

Cholestasis Incidence: <1.0%* Severity: MODERATE
Onset: DELAYED

Hemolytic Anemia Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Aplastic Anemia Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Joint Pain Incidence: <0.1%* Severity: MILD
Onset: DELAYED

No White Blood Cells Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Low Blood Sodium Levels Incidence: <0.1%* Severity: MODERATE
Onset: DELAYED

Muscle Pain Incidence: <0.1%* Severity: MILD
Onset: EARLY

SIADH Incidence: <0.1%* Severity: SEVERE
Onset: DELAYED

Low Platelet Count Incidence: <0.1%* Severity: MODERATE
Onset: DELAYED

Skin Redness Incidence: 1.5%* Severity: MODERATE
Onset: EARLY

Itching Incidence: 1.5%* Severity: MILD
Onset: RAPID

Rash With Pustules Incidence: 1.5%* Severity: MILD
Onset: EARLY

Hives Incidence: 1.5%* Severity: MILD
Onset: RAPID

Low Blood Sugar Incidence: 1.8-39.0%* Severity: MODERATE
Onset: EARLY

Heartburn Incidence: 1.8%* Severity: MILD
Onset: EARLY

Upset Stomach Incidence: 1.8%* Severity: MILD
Onset: EARLY

Weight Gain Incidence: >10.0%* Severity: MILD
Onset: DELAYED

Secondary Failure Incidence: 21.8-46.8%* Severity: SEVERE
Onset: DELAYED

*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.

Daily Life Interactions for Glyburide (Micronized) 1.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Close All Interactions

Moderate Lifestyle Interaction

Alcohol and Glyburide (Micronized) 1.5mg Tablet(Glyburide, Micronized)

Alcohol and Sulfonylureas(Glyburide, Micronized)

It is best to limit the ingestion of alcohol during use of this medicine. Alcohol can increase the risk for severe or prolonged low blood sugar. If you do choose to drink alcohol, make sure you do not take it on an empty stomach. Frequently monitor your blood sugar. Know the signs and symptoms of low blood sugar and how to treat them. Do not drive or operate machinery, or perform other hazardous tasks while ingesting alcohol.

Minor Lifestyle Interaction

Tobacco and Glyburide (Micronized) 1.5mg Tablet(Glyburide, Micronized)

Tobacco and Sulfonylureas(Glyburide, Micronized)

If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the actions of Antidiabetic Agents (medicines used to treat diabetes) may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.

Check Drug Interactions

Pregnancy & Lactation Information

First Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Second Trimester

Third Trimester

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.

Learning More About

Visit the Drug Summary page where you can: